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Abstract: Wissadula periplocifolia (L.) C. Presl (Malvaceae) is commonly used in Brazil to treat
bee stings and as an antiseptic. The antioxidant properties of its extracts have been previously
demonstrated, thus justifying a phytochemical investigation for its bioactive phenolic constituents.
This has yielded five new sulphated flavonoids: 8-O-sulphate isoscutellarein (yannin) (1a);
41-O-methyl-7-O-sulphate isoscutellarein (beltraonin) (1b); 7-O-sulphate acacetin (wissadulin) (2a);
41-O-methyl-8-O-sulphate isoscutellarein (caicoine) (2b) and 31-O-methyl-8-O-sulphate hypolaetin
(pedroin) (3b) along with the known flavonoids 7,41-di-O-methyl-8-O-sulphate isoscutellarein (4),
acacetin, apigenin, isoscutellarein, 41-O-methyl isoscutellarein, 7,41-di-O-methylisoscutellarein,
astragalin and tiliroside. The compounds were isolated by column chromatography and identified
by NMR (1H, 13C, HMQC, HMBC and COSY) and LC-HRMS. A cell based assay was carried out
to evaluate the preliminary cytotoxic properties of the flavonoids against UVW glioma and PC-3M
prostate cancer cells as well as non-tumour cell lines. The obtained results showed that acacetin,
tiliroside, a mixture of acacetin + apigenin and the sulphated flavonoids 2a + 2b exhibited inhibitory
activity against at least one of the cell lines tested. Among the tested flavonoids acacetin and
tiliroside showed lower IC50 values, presenting promising antitumor effects.
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1. Introduction
The Malvaceae family is estimated to contain 243 genera with 4225 species. They have
a cosmopolitan distribution and are predominant in the tropics [1]. The family is known to be
rich in flavonoids [2–4] and sulphur compounds have been reported from a few species such as
Malva sylvestris L. and Sidastrum micranthum (A. St.-Hil.) Fryxell [5–7].
Sulphated flavonoids represent an uncommon group of interesting compounds found in some
plant families such as Asteraceae, Bixaceae, Dilleniaceae and Verbenaceae [8,9]. These compounds
are usually single sulphate or multi-sulphate esters of known flavonoids. The first reported sulphated
flavonoid, isorhamnetin 3-sulphate, was isolated in 1937 from Polygonum hydropiper L. (Polygonaceae)
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found in swampy areas of Europe [10]. Thus it was demonstrated that a strong correlation exists
between plants growing in aquatic habitats rich in mineral salts and the synthesis of sulphated
flavonoids. Therefore, the sulphation of flavonoids could be considered as a result of an ecological
adaptation [11,12]. Sulphated flavonoids seem to have an important role in regulation of plant growth
and co-pigmentation by forming stable complexes with anthocyanin pigments [13,14]. Sulphation
is also considered a detoxification pathway, but in the plant kingdom many other biological
functions related to this transformation continue to be discovered including molecular recognition
and signaling pathways [15]. The transfer of the functional sulphur group to hydroxylated substrates
is catalyzed by a family of sulphotransferase isoforms (SOT). The SOT-catalyzed sulphation requires
31-phosphoadenosine 51-phosphosulphate as the sulphate donor and compounds with free hydroxyl
groups, i.e., flavonoids, as acceptors [16]. Several sulphated flavonoids have already been described
for their antiviral and anticoagulant activities [17–19].
Wissadula periplocifolia (L.) C. Presl (Malvaceae) is known in Brazil as “malva amarela” and is
used to treat bee stings and as an antiseptic [20]. Previous studies have demonstrated its great
antioxidant potential, thus justifying a phytochemical examination for phenolic compounds [4]. This
study reports the phytochemical investigation of W. periplocifolia and the isolation of new sulphated
flavonoids along with known flavonoids. In addition, cytotoxic properties of the compounds
were evaluated.
2. Results and Discussion
2.1. Structure Elucidation of Compounds
Chromatographic procedures led to the isolation of flavonoids from aerial parts of
W. periplocifolia. The compounds were identified by analyzing their 1D and 2D NMR data, and
confirmed by their accurate masses and molecular formulas obtained with LC-HRMS.
The 1H-NMR of 1 showed a complex set of signals in the δH 6 to 8 ppm range and the presence of
two downfield singlets at δH 12.75 and δH 12.16, characteristic of flavonoids with H-bonded hydroxyl
proton at C-5 and the possibility of being a mixture of two flavonoids. The 13C-NMR spectrum
showed 31 signals and using the HMBC, HMQC and COSY spectra it was possible to identify the
compounds in the mixture. The major constituent 1a showed singlets at δH 6.81 attached to C-3
and at δH 6.29 attached to C-6 (HSQC). Two doublets at δH 8.03 (2H, J = 8.74 Hz) and δH 6.93 (2H,
J = 8.75 Hz) indicated a para-substituted B ring with a scaffold similar to isoscutellarein [21] (Table 1).
However, comparison with isoscutellarein 13C-NMR data showed that for compound 1a the signal
for C-8 is shielded by 4 ppm while C-7, C-9 and C-5 were deshielded by about 4 ppm. Besides,
1a was found to be more polar than isoscutellarein, moving slower on TLC. These facts suggest
an O-sulphate group attached at C-8 instead of a hydroxyl as for isoscutellarein. These chemical
shifts are usually observed for O-sulphate flavonoids [17,22]. The presence of O-sulphate group was
confirmed by LC-HRMS. The minor constituent 1b showed singlets at δH 6.93 attached to C-3 and
δH 6.90 attached to C-6, two doublets at δH 8.11 (2H, J = 8.88 Hz) and δH 7.14 (2H, J = 8.90 Hz)
and a methoxyl at δH 3.86 (Table 1). The HMBC showed a strong correlation of the methoxyl with
a carbon at δc 163.0, confirming the methoxyl to be at C-4
1. Comparison of the NMR data of 1b and
41-O-methylisoscutellarein [23] indicated that position 7 was shielded by 5 ppm, and positions C-6
and C-8 were found to be deshielded by 4 and 6 ppm. Like compound 1a, an O-sulphate substitution
is proposed, but for 1b this group is found at C-7. In order to confirm the O-sulphate group in 1a and
1b, the HRMS of the compounds were obtained by LC-HRMS. The accurate mass (molecular formula)
for compound 1a as [M ´ H]´ ion, found at retention time (RT) of 5.34 min, was 365.0049 (C15H9O9S)
and for compound 1b also as an [M ´ H]´ ion (RT: 6.05 min) was 379.0206 (C16H11O9S). These results
confirm the presence of O-sulphate groups in both molecules. Thus, compound 1a was identified as
8-O-sulphate isoscutellarein (yannin) and compound 1b as 41-O-methyl-7-O-sulphate isoscutellarein
(beltraonin) (Figure 1) and are hereby reported for the first time.
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Table 1. NMR data (DMSO-d6,
1H 400 MHz and 13C 100 MHz) of O-sulphated flavonoids fromWissadula periplocifolia.
Position
1a 1b 2a 2b 3b 4
δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC δH (J in Hz) δC
2 - 164.5, C - 164.3, C - 164.3, C - 163.9, C - 164.4, C - 164.4, C
3 6.81, s 103.1, CH 6.93, s 103.9, CH 6.93, s 104.2, CH 6.89, s 103.7, CH 6.87, s 103.3, CH 6.87, s 103.3, CH
4 - 182.5, C - 183.1, C - 182.6, C - 182.4, C - 182.5, C - 182.8, C
5 - 157.5, C - 152.0, C - 161.0, C - 157.4, C - 157.5, C - 157.6, C
6 6.29, s 100.0, CH 6.90, s 104.1, CH 6.60, d (1.8) 102.1, CH 6.30, s 100.0, CH 6.29, s 99.9, CH 6.53, s 96.6, CH
7 - 157.5, C - 148.3, C - 160.1, C - 157.5, C - 157.5, C - 159.7, C
8 - 121.9, C - 129.5, C 7.05, d (1.8) 98.0, CH - 121.9, C - 121.1, C - 123.3, C
9 - 150.2, C - 145.7, C - 156.9, C - 150.1, C - 151.9, C - 149.9, C
10 - 104.4, C - 106.8, C - 106.2, C - 104.4, C - 104.4, C - 104.3, C
11 - 121.9, C - 123.5, C - 123.1, C - 123.4, C - 122.3, C - 123.7, C
21 8.03, d (8.7) 129.0, CH 8.11, d (8.9) 129.3, CH 8.07, d (8.7) 129.0, CH 8.14, d (8.9) 129.1, CH 7.64, dd (1.8, 8.5) 121.1, CH 8.28, d (8.7) 129.7, CH
31 6.93, d (8.7) 116.4, CH 7.14, d (8.9) 115.2, CH 7.12, d (8.7) 115.1, CH 7.13, d (8.9) 115.0, CH 7.14, dd (0.7, 8.5) 115.2, CH 7.08, d (8.7) 114.9, CH
41 - 161.8, C - 163.0, C - 162.9, C - 162.9, C - 151.2, C - 162.8, C
51 6.93, d (8.7) 116.4, CH 7.14, d (8.9) 115.2, CH 7.12, d (8.7) 115.1, CH 7.13, d (8.9) 115.0, CH - 148.5, C 7.08, d (8.7) 114.9, CH
61 8.03, d (8.7) 129.0, CH 8.11, d (8.9) 129.3, CH 8.07, d (8.7) 129.0, CH 8.14, d (8.9) 129.1, CH 7.82, d (1.8) 111.2, CH 8.28, d (8.7) 129.7, CH
OCH3-4
1 - - 3.86, s 56.1, CH3 3.86, s 56.0, CH3 3.87, s 56.0, CH3 - - 3.86, s 56.1, CH3
OCH3-7 - - - - - - - - - - 3.85, s 57.0, CH3
OCH3-5
1 - - - - - - - - 3.88, s 56.4, CH3 - -
OH-5 12.75, s - 12.16, s - 12.82, s - 12.70, s - 12.71, s - 12.87, s -
OH-8 - - 8.98, s - - - - - - - - -
OH-7 9.96, s - - - - - - - - - - -
OH-41 10.42, s - - - - - - - - - - -
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The 1H-NMR of 2 showed a similar pattern to 1. There were also two downfield singlets
at δH 12.82 and δH 12.70 integrating for 1.0 and 0.51, respectively. The set of aromatic protons
also indicated that 2 was a mixture of two flavonoids. Additionally, a signal corresponding to
methoxyl protons was integrated for 4.61, suggesting the presence of one methoxyl for each flavonoid
in the mixture. The 13C-NMR spectra also showed 31 signals including a duplicated methoxyl
carbon at δc 56.03. By analyzing the HMBC and HMQC spectra of this mixture, it was possible to
determine the major constituent (compound 2a) to possess an acacetin-like moiety and the minor
one (compound 2b) showed a 41-O-methyl isoscutellarein skeleton. However, comparison of 2a with
acacetin NMR data indicated that C-7 in compound 2a is shielded by 4 ppm and C-6, C-8 and C-10
are deshielded by 3 ppm [3]. This is the same chemical shift difference observed for compound 1b,
indicating that compound 2a is substituted by an O-sulphate at C-7. Comparison of the NMR data
of compound 2b with 41-O-methyl isoscutellarein also indicated some chemical shift differences: C-8
is shielded by 4 ppm while C-7, C-5 and C-9 were deshielded by 4 ppm, thus compound 2b may
possess an O-sulphate at C-8 just like 1a [23]. The accurate masses obtained for the [M ´ H]´ ions
were 363.0258 (RT: 5.20 min) (2a) and 379.0204 (RT: 6.50 min) (2b), and the molecular formulas found
were C16H11O8S and C16H11O9S respectively. Compound 2a was identified as 7-O-sulphate acacetin
(wissadulin) and compound 2b was identified as 41-O-methyl-8-O-sulphate isoscutellarein (caicoine)
(Figure 1), both reported for the first time.
Έ
Έ
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Figure 1. Compounds isolated fromWissadula periplocifolia.
Similar to the mixtures of 1 and 2, the 1H-NMR of 3 indicated the presence of a mixture of two
flavonoids. The two downfield singlets were found at δH 12.75 and δH 12.71 integrated for 1.0 and
0.47 respectively. Using the NMR data of 3 the major compound of this mixture 3a was found to be
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similar to compound 1a (yannin). The minor constituent of the mixture (compound 3b) showed two
singlets at δH 6.87 and δH 6.29 integrated for 1H each and another singlet at δH 3.88 integrated for
3H suggesting the presence of a methoxyl group. A set of doublets at δH 7.82 (1H; d, J = 1.8 Hz),
δH 7.64 (1H; dd, J = 1.8 and 8.5 Hz) and δH 7.14 (1H; dd, J = 0.7 and 8.5 Hz), indicated that ring B
is substituted at positions 31 and 41. From the HMBC and HMQC spectrum of this mixture it was
possible to determine that 3b possesses a 31-O-methylhypoaletin skeleton [24]. When compared to
literature NMR data, 3b showed that C-8 was more shielded while C-7 and C-9 were deshielded,
indicating that 3b may have an O-sulphate group at C-8 of a 31-O-methylhypoaletin skeleton. The
accurate mass and the molecular formula of compound 3b [M ´ H]´ ion were obtained as 395.0136
and C16H11O10S (RT 5.41 min), respectively, thus the structure of compound 3b was determined
as 31-O-methyl-8-O-sulphate hypoaletin (pedroin) (Figure 1) and it is also being reported for the
first time.
Compound 4 showed a skeleton similar to 7,41-di-O-methylisoscutellarein [3]. As observed
for the other O-sulphated flavonoids, differences in chemical shifts were found for C-8 which was
3 ppm shielded while C-7 and C-9 were 4 ppm deshielded as in 1a, 2b and 3b. The accurate mass
obtained for the [M ´ H]+ ion (RT 6.15 min) of compound 4 was 395.0405 and the molecular formula
C17H15O9S allowed its identity to be confirmed as 7,4
1-di-O-methyl-8-O-sulphate isoscutellarein
(Figure 1), previously reported from Sidastrum micranthum (Malvaceae) [7].
The non-sulphated flavonoids isolated from W. periplocifolia were identified by comparisons of
their NMR data with literature (see Experimental). They are being reported for the first time from
Wissadula genera.
2.2. Evaluation of Cytotoxicity
The cytotoxic evaluation of the flavonoids from W. periplocifolia against tumour (UVW, PC-3M)
and non-tumour (PNT2A, Hs27) cell lines was accomplished by the alamarBlue assay. Among
all tested fractions, only acacetin, tiliroside, a mixture of acacetin + apigenin and the sulphated
flavonoids 2a + 2b exhibited inhibitory activity against at least one of the cell lines tested. Table 2
shows the 50% inhibitory concentrations (IC50) of the tested samples on each cell line. Comparison
between IC50 values shows that the treatment with these flavonoids (0.4–100 µg/mL) for 24 h exerted
higher anti-proliferative activity against tumour cells (mainly PC-3M prostate carcinoma cells), when
compared to both non-cancer cell lines.
Table 2. IC50 for 24h treatment withWissadula periplocifolia compounds in different cell lines.
Treatment
IC50 (µg/mL)
Tumour Cell Lines Normal Cell Lines
UVW PC-3M PNT2A Hs27
acacetin 27.37 ˘ 1.09 ab 21.13 ˘ 1.16 ab 51.33 ˘ 1.09 >100
7,41-di-O-methylisoscutellarein 98.55 ˘ 1.13 ab >100 88.73 ˘ 1.13 NA
tiliroside >100 60.55 ˘ 1.12 ab >100 NA
acacetin + apigenin (1.2:1) >100 48.13 ˘ 1.09 ab >100 >100
2a + 2b (2:1) >100 92.14 ˘ 1.09 ab >100 NA
The values are means ˘ SD of at least three independent experiments performed in duplicates. NA = not
applicable. a p < 0.05 compared to PNT2A; b p < 0.05 compared to Hs27.
Among the flavonoids from W. periplocifolia tested, 7,41-di-O-methylisoscutellarein and the
sulphated flavonoids 2a + 2b presented anti-proliferative effects against UVW and PC-3M cells,
respectively, but with higher IC50 values. Acacetin exhibited the best cytotoxicity against UVW and
PC-3M cells, with the lowest IC50 values. Most importantly, the anti-proliferative effects of acacetin
were higher in tumour cells when compared to non-cancer cell lines. It has been shown that acacetin
exhibits anti-proliferative activities against many tumour cell lines [25–27], including glioma and
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prostate carcinoma cells. However, its underlying mechanisms of action remain unknown. In glioma
cells, acacetin inhibits the production of TGF-β1, an angiogenic cytokine [28]. In prostate cancer
cells, acacetin effects occur via apoptotic pathways that target Akt/NF-κB signalling [29], inhibit
JAK1/2 and STAT3 signaling [30], or is accompanied by poly-(ADP-ribose) polymerase cleavage.
It can act through inhibition of cell cycle progression as well. In addition, in DU145 human prostate
carcinoma cell line, the treatment with acacetin induces down regulation of the expression of matrix
metalloproteinase-2 (MMP-2), matrixmetalloproteinase-9 (MMP-9), and urokinase-type plasminogen
activator (u-PA) through suppressing p38 MAPK signaling pathway, proving that it might also be
used as an antimetastatic agent [31].
Apigenin is another flavone that decreases viability of many cancer cells through mechanisms
that had not been completely explored so far [32–37]. Nevertheless, in our assays, apigenin did not
present a synergistic effect with acacetin. The mixture of acacetin + apigenin (1.2:1) was not toxic to
UVW cells and exhibited lower inhibitory activity against PC-3M cells compared to treatment with
apigenin alone.
Tiliroside isolated fromW. periplocifolia exerted selective anti-proliferative activity against PC-3M
prostate carcinoma cells, when compared to glioma and both non-cancer cell lines. Tiliroside is
a naturally occurring flavonoid that has toxic effects on some tumour cell lines such as lung cancer
A549 [38] and no significant cytotoxic action on many other cell lines such as DMS114, H460,
MCF7, MB435, DU145, SF268, HT29, HCT116, NCI-H292, HEp-2 and KB cells [39,40]. In human
endometrial carcinoma cells that were subjected to oxidative stress, the treatment with tiliroside could
restore all the alterations on the cells to the control level, thereby showing an antioxidative action of
this flavonoid through insulin-like growth factor-I receptor (IGF-IR) signalling [41]. However, the
peracetylated derivate of tiliroside presents anti-proliferative action on many tumour cells. Thus, the
strategy of peracetylation improves its cytotoxic effects [40,42]. Tiliroside significantly inhibited the
growth of sarcoma 180 and carcinoma of Ehrlich tumours that were implanted in mice, even though
the flavonoid was not toxic to some tumour cell lines tested in vitro. Therefore, tiliroside presents
promising antitumor effects without a significant toxicity [39].
In this study, we showed preliminary cytotoxic characterizations of flavonoids isolated from
W. periplocifolia on glioma and prostate cancer cell lines. Further analyses are necessary to investigate
the mechanisms of action of these compounds.
3. Experimental Section
3.1. General Procedures
Column chromatography separations (CC) were performed on glass columns packed with silica
gel (ASTM, 230-400 mesh, Merck, Nottingham, UK) and gel filtration chromatography (GFC) were
carried out using Sephadex LH-20 (Sigma-Aldrich, Irvine, UK). Thin layer chromatography (TLC)
were performed on silica gel PF 254 plates (Merck, Nottingham, UK) and spots were visualized
under UV light (254 and 366 nm) and by spraying with vanillin–sulphuric acid reagent. Isolated
compounds were identified by 1D and 2D NMR analysis (1H 400 MHz, 13C 100 MHz), acquired on
a Bruker-Avance III spectrometer (Bruker, Coventry, UK) using deuterated DMSO.
3.2. Plant Material
The aerial parts of W. periplocifolia were collected in Araruna City, Paraiba/Brazil (GPS
coordinates 6˝2712911S 35˝4014311W), in August 2005 (SISBIO Authorization Number 46923-2).
A voucher specimen (JPB 6498) was authenticated by Prof. Dr. Maria de Fátima Agra and deposited
at Prof. Lauro Pires Xavier Herbarium (JPB/UFPB).
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3.3. Extraction and Isolation
The plant material was dried in an oven at 40 ˝C for 72 h. After milling, 8.9 kg of powder
was macerated with absolute ethanol for 72 h. The obtained ethanol extract was concentrated with
a rotatory evaporator yielding 705 g of crude extract (CEE). 200 g of CEE was solvent extracted using
hexane, dichloromethane (CH2Cl2), ethyl acetate (EtOAc) and n-butanol to yield 48 g of hexane (HF),
33 g of CH2Cl2 (DF), 28 g of EtOAc (EAF) and 9 g of n-butanol (BF) fractions. The various fractions
were analysed by 1H-NMR to detect the presence of phenolic constituents and DP, EAP and BF were
chosen for column chromatography (CC).
The fraction DF (15 g) was subjected to silica column chromatography (CC) eluted with
hexane, EtOAc and methanol in a gradient manner. The fractions were analysed by TLC and
interesting fractions were further subjected to GFC, eluted isocratic wise with methanol to isolate
the compounds. CC fraction 58–69 chromatographic separation on GFC led to isolation of acacetin
(35 mg) and 7,41-di-O-methylisoscutellarein (24 mg), identified by NMR and LC-MS techniques and
by comparisons with literature data. CC fraction 79–92 on GFC yielded the compounds apigenin,
isoscutellarein, and 41-O-methyl isoscutellarein. Their NMR data match with literature [21,23].
The CC fraction 206–218 (246 mg) was subjected to GFC yielding 34 fractions. These fractions
were analyzed by TLC and combined. Fractions 16–17 (12 mg) and 20–21 (9 mg) showed only one
spot at TLC, named as compounds 1 and 2 respectively (Figure 1 and Table 1). The CC combined
fraction 219–227 (210 mg) was chromatographed under GFC resulting in 35 fractions. Fraction 31–35
(60 mg) was again subjected to GFC yielding 14 fractions. The resulting fractions were analyzed by
TLC and the sample 4–10 (10 mg) showed one spot at TLC and it was coded as compound 3 (Figure 1
and Table 1).
EAF (2 g) was subjected to GFC eluted with methanol. Fractions were analyzed by
TLC and selected to purification also through GFC. From this process two glucosyl flavonoids
were purified: kaempferol 3-O-β-D-glucopyranoside (astragalin) (12 mg) and kaempferol-3-O-b-
D-(611-E-p-coumaroyl) glucopyranoside (tiliroside) (95 mg). The purified fractions were analyzed by
1D and 2D NMR techniques and by LC-MS and the data match with literature [3,43].
BF (2 g) was subjected to consecutives GFC eluted with methanol. From this process it was
purified compound 4 (32 mg) (Figure 1 and Table 1) and the tiliroside, also isolated from EAF.
3.4. Compound Identification
The isolated compounds were identified by 1D and 2D NMR analysis (1H 400 MHz,
13C 100 MHz) using deuterated DMSO, and their mass spectra were obtained by LC-HRMS. The
NMR data of compounds 1 to 4 are showed at Table 1. The NMR spectra and HRMS of compounds 1
to 4 can be found at Supplementary Material (Figure S1–S26).
Acacetin. 1H-NMR (DMSO) δ (ppm): 12.93 (s, 5-OH), 6.88 (s, H-3), 6.20 (d, J = 2 Hz, H-6), 6.51 (d,
J = 2 Hz, H-8), 8.12 (d, J = 8.5 Hz, H-21, H-61), 7.11 (d, J = 8.5 Hz, H-31, H-51), 3.86 (s, -OCH3-C4
1).
13C-NMR (DMSO) δ (ppm): 163.8 (C-2), 104.1 (C-3), 182.3 (C-4), 162.0 (C-5), 99.4 (C-6), 164.7 (C-7),
94.60 (C-8), 157.9 (C-9), 104.3 (C-10), 123.3 (C-11), 128.8 (C-21, C-61), 115.1 (C-31, C-51), 162.8 (C-41), 56.1
(-OCH3-4
1). The 1H- and 13C-NMR spectral data are consistent with published data [3].
Apigenin. 1H-NMR (DMSO) δ (ppm): 12.96 (s, 5-OH), 6.78 (s, H-3), 6.19 (d, J = 1.8 Hz, H-6), 6.48 (d,
J = 1.8 Hz, H-8), 7.92 (d, J = 8.7 Hz, H-21, H-61), 6.93 (d, J = 8.7 Hz, H-31, H-51). 13C-NMR (DMSO)
δ (ppm): 164.3 (C-2), 103.4 (C-3), 182.3 (C-4), 162.0 (C-5), 99.4 (C-6), 164.7 (C-7), 94.5 (C-8), 157.9 (C-9),
104.2 (C-10), 121.7 (C-11), 129.0 (C-21, C-61), 116.5 (C-31, C-51), 161.7 (C-41). The 1H- and 13C-NMR
spectral data are consistent with published data [21].
Isoscutellarein. 1H-NMR (DMSO) δ (ppm): 12.39 (s, 5-OH), 6.74 (s, H-3), 6.27 (s, H-6), 8.01 (dd,
J = 8.7 and 2.3 Hz, H-21, H-61), 6.93 (dd, J = 8.7 and 2.3 Hz, H-31, H-51). 13C-NMR (DMSO) δ
(ppm): 164.1 (C-2), 102.9 (C-3), 182.7 (C-4), 153.6 (C-5), 99.2 (C-6), 153.9 (C-7), 125.6 (C-8), 146.0 (C-9),
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103.8 (C-10), 121.9 (C-11), 129.2 (C-21, C-61), 116.4 (C-31, C-51), 161.7 (C-41). The 1H- and 13C-NMR
spectral data are consistent with published data [21].
41-O-Methyl isoscutellarein. 1H-NMR (DMSO) δ (ppm): 12.40 (s, 5-OH), 6.83 (s, H-3), 6.28 (s, H-6), 8.12
(d, J = 8.9 Hz, H-21, H-61), 7.12 (dd, J = 8.9 Hz, H-31, H-51), 3.86 (s, -OCH3-C4
1). 13C-NMR (DMSO)
δ (ppm): 163.7 (C-2), 103.6 (C-3), 182.7 (C-4), 153.6 (C-5), 99.2 (C-6), 153.6 (C-7), 125.6 (C-8), 146.0 (C-9),
103.9 (C-10), 123.6 (C-11), 129.0 (C-21, C-61), 115.1 (C-31, C-51), 162.8 (C-41), 56.1(-OCH3-4
1). The 1H- and
13C-NMR spectral data are consistent with published data [23].
7,41-di-O-Methyl isoscutellarein. 1H-NMR (DMSO) and 13C-NMR (DMSO) δ (ppm). Previously
reported [44].
Tiliroside. 1H-NMR (DMSO) δ (ppm): 12.55 (s, 5-OH), 6.13 (d, J = 2.0 Hz, H-6), 6.38 (d, J = 2.0 Hz,
H-8), 7.97 (d, J = 8.8 Hz, H-21/61), 6.85 (d, J = 8.8 Hz, H-31/51), 5.43 (d, J = 7.3 Hz, H-111), 3.18–3.40 (m,
H-211, 311, 411, 511), 4.02–4.27 (m, H-611), 7.34 (d, J = 8.5 Hz, H-2111/6111), 6.78 (d, J = 8.5 Hz, H-3111/5111),
7.31 (d, J = 16 Hz, H-β), 6.08 (d, J = 16 Hz, H-α). 13C-NMR (DMSO) δ (ppm): 157.1 (C-2), 133.5
(C-3), 177.9 (C-4), 161.7 (C-5), 99.3 (C-6), 164.7 (C-7), 94.2 (C-8), 156.9 (C-9), 102.5 (C-10), 121.3 (C-11),
130.7 (C-21/61), 116.3 (C-3111/5111), 160.5 (C-41), 101.4 (C-111), 74.8 (C-211), 76.7 (C-311), 70.5 (C-411), 74.6
(C-511), 63.4 (C-611), 125.4 (C-1111), 131.3 (2111 and 6111), 115.6 (C-3111 and 5111), 160.3 (C-4111), 145.2 (C-7111),
114.1 (C-8111), 166.7 (C-9111). The 1H- and 13C-NMR spectral data are consistent with published data [3].
Astragalin. 1H-NMR (DMSO) δ (ppm): 12.549 (s, 5-OH), 6.20 (d, J = 2.0 Hz, H-6), 6.00 (d, J = 2.0 Hz,
H-8), 8.01 (d, J = 8.8 Hz, H-21/61), 6.85 (d, J = 8.8 Hz, H-31/51), 5.37 (d, J = 7.3 Hz, H-111), 3.15–3.55 (m,
H-211, 311, 411, 511, 611). 13C-NMR (DMSO) δ (ppm): 155.6 (C-2), 133.5 (C-3), 177.1 (C-4), 160.5 (C-5), 101.9
(C-6), 163.1 (C-7), 94.9 (C-8), 155.7 (C-9), 103.5 (C-10), 122.7 (C-11), 131.2 (C-21/61), 115.5 (C-3111/5111),
160.5 (C-41), 101.9 (C-111), 74.7 (C-211), 77.9 (C-311), 70.3 (C-411), 76.9 (C- 511), 61.3 (C-611). The 1H- and
13C-NMR spectral data are consistent with published data [43].
3.5. Liquid Chromatography-Mass Spectrometry (LC-MS)
In order to confirm the compounds structures, the high-resolution mass spectra was obtained
by LC-MS analysis performed on an Accela 600 HPLC system combined with an Exactive (Orbitrap)
mass spectrometer from Thermo Fisher Scientific (Bremen, Germany) in negative or positive mode
using method developed to separate phenolic compounds [44].
Each sample was dissolved in methanol (HPLC grade) to obtain a final concentration of
1 mg/mL. The injection volume was 20 µL and an ACE C-18 column (150 ˆ 3 mm, 3 µm) from
HiChrom (Reading, UK) was used. A flow rate of 300 µL/min and a mobile phase composed of
0.1% formic acid in H2O (solvent A) and acetonitrile (solvent B) was used in a gradient mode as
summarized in the Table 3. Data were analysed using Xcalibur 2.2 from Thermo Fisher Scientific.
Table 3. Gradient method used at LC-HRMS experiment.
Time (min) A% B%
0 75 25
15 25 75
3.6. Cell lines and Cell Culture
All media and supplements were obtained from Invitrogen (Paisley, UK). The following human
cell lines were used in the current study: the human glioma cancer cell line (UVW) previously
described [45], the prostate carcinoma cell line (PC-3M), the normal prostate epithelial cell line
(PNT2A), and the normal foreskin fibroblast cell line (Hs27) [46]. All cell lines were obtained from
in house stocks (UVW) or from stocks purchased from the ATCC (Rockville, MD, USA) and are
routinely genetically verified and confirmed as free frommycoplasma contamination. UVW, PNT2A,
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and Hs27 cells were maintained in Eagle’s Minimum Essential Medium (MEM), RPMI 1640 Medium,
and Dulbecco’s Modified Eagle’s Medium (DMEM), respectively. All media were supplemented
with 10% v/v fetal bovine serum, penicillin (100 units/mL), streptomycin (100 µg/mL), Fungizone
(2.5 µg/mL of amphotericin B), and L-glutamine (2 mM). The PC-3M cells were cultured in the same
MEM medium as described for UVW cells with the addition of 1% v/v MEM Non-essential Amino
Acids Solution, 1% v/vMEM Vitamin Solution, and 1mM sodium pyruvate. The cells were cultured
at 37 ˝C in a humidified atmosphere of 5% CO2.
3.7. Evaluation of Cytotoxicity
Each sample tested was dissolved in DMSO at 50 mg/mL and kept at ´20 ˝C until extract
preparation was proceeded. For the biological assays, the samples were diluted in culture medium
to get the selected concentrations. The toxicity of the flavonoids on UVW, PC-3M, PNT2A, and
Hs27 cells was assessed by the fluorometric measurement of metabolic activity using the AlamarBlue
assay (Invitrogen) [46]. Briefly, cells were seeded on 96-well culture plates (3.3 ˆ 103cells/well).
After 24 h incubation, the medium was replaced by fresh media containing the flavonoid fractions
at 0.4, 1.2, 3.7, 11.1, 33.3, and 100 µg/mL or DMSO at 0.5% v/v, and then cultured for 24 h at
37 ˝C in a humidified atmosphere of 5% CO2. Untreated cells were used as negative controls. After
treatment, the culture medium was removed and replaced by fresh media containing alamarBlue
(10% v/v), and the dye was incubated in the plates with the cells for 4 h. Fluorescence was measured
on a micro plate fluorescence reader (Spectramax Gemini XS, Molecular Devices, Sunnyvale, CA,
USA) using an excitation wavelength of 560 nm and an emission wavelength of 590 nm. Cell
viability was calculated and plotted as the percentage of metabolically active cells relative to the
control. The 50% inhibitory concentrations (IC50) were calculated graphically from the individual
concentration–response curves by non-linear curve fitting. Two-way analysis of variance (two-way
ANOVA) with Bonferroni post-hoc test was used to compare the 50% inhibitory concentration values.
The level of significance was set at p < 0.05 and statistical analysis was performed using GraphPad
Prism version 5.0 for Windows (GraphPad Software, San Diego, CA, USA).
4. Conclusions
The present study has led to the identification of five new sulphated flavonoids from Wissadula
periplocifolia: 8-O-sulphate isoscutellarein (1a); 411-O-methyl-7-O-sulphate isoscutellarein (1b);
7-O-sulphate acacetin (2a); 41-O-methyl-8-O-sulphate isoscutellarein (2b) and 31-O-methyl-8-O-
sulphate hypolaetin (3b) along with the known flavonoids 7,41-di-O-methyl-8-O-sulphate
isoscutellarein (4), acacetin, apigenin, isoscutellarein, 41-O-methyl isoscutellarein, 7,41-di-O-methyl
isoscutellarein, astragalin and tiliroside. Besides, the cytotoxic properties of the isolated compounds
were evaluated demonstrating the potential cytotoxicity of acacetin, 7,41-di-O-methyl isoscutellarein,
apigenin and the new compounds 7-O-sulphate acacetin (2a) and 41-O-methyl-8-O-sulphate
isoscutellarein (2b).
Supplementary Materials: The NMR and HRMS spectra of compounds 1 to 4 are available online at
http://www.mdpi.com/1420-3049/20/11/19685/s1.
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